RecruitingNot applicableNCT05897879
Impact of Bacterial Expression and Immune Response in the Severity of Pertussis
Studying Whooping cough
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institut Pasteur
- Principal Investigator
- Julie Toubiana, MDInstitut Pasteur
- Intervention
- Nasopharyngeal swab(biological)
- Enrollment
- 210 enrolled
- Eligibility
- 15 years · All sexes
- Timeline
- 2023 – 2026
Study locations (14)
- CHU de Bordeaux, Bordeaux, France
- Hôpital Louis Mourier, Colombes, France
- Centre hospitalier intercommunal de Créteil, Créteil, France
- Hôpital Roger Salengo, Lille, France
- Hospices Civils de Lyon, Lyon, France
- Hôpital de la Timone Enfants, APHM, Marseille, France
- Hôpital Nord, APHM, Marseille, France
- CHU de Nantes, Nantes, France
- CHU Armand Trousseau, Paris, France
- Hopital Necker, Paris, France
- Hôpital Robert Debré, Paris, France
- CHU Rouen, Rouen, France
- Réseau ACTIV, Saint-Maur-des-Fossés, France
- CHU de Toulouse, Toulouse, France
Collaborators
Hôpital Necker-Enfants Malades · Hospices Civils de Lyon · Hopital Universitaire Robert-Debre · Centre Hospitalier Intercommunal Creteil · Nantes University Hospital · Réseau ACTIV · Hôpital Armand Trousseau · CHR - Hôpital Roger Salengo · Hôpital Nord - APHM · Hôpital Louis Mourier · University Hospital, Toulouse · University Hospital, Bordeaux · Hôpital de la Timone · University Hospital, Rouen
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05897879 on ClinicalTrials.govOther trials for Whooping cough
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06827470Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella PertussisDalhousie University
- RECRUITINGPHASE4NCT0680352410-year Follow-up After a Single Dose Acellular Pertussis VaccinationMahidol University
- ACTIVE NOT RECRUITINGPHASE3NCT06798831Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in AdultsBioNet-Asia Co., Ltd.
- ACTIVE NOT RECRUITINGNCT06888076Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Pregnant WomenBioNet-Asia Co., Ltd.
- RECRUITINGPHASE4NCT06903221A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation with Bordetella Pertussis Using Controlled Human InfectionDimitri Diavatopoulos
- RECRUITINGNCT06286007Prevalence and Impact of Pertussis and RSV on Asthma Severity and ControlHospital Clinico Universitario de Santiago
- RECRUITINGNANCT05847322Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 WeeksUniversity of Southampton
- ACTIVE NOT RECRUITINGPHASE4NCT05264662Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant WomenFarzanah Laher